Ocugen Inc (OCGN)

NASDAQ HEALTHCARE
$1.38 -2.13% RSI 39 Neutral Add Alert

Moving Averages

SMA 200
$1.49
Price below

Company Profile

Ocugen, Inc., a clinical-stage biopharmaceutical company, focuses on the development of gene therapies to cure diseases of blindness. The company is headquartered in Malvern, Pennsylvania.

Sector
HEALTHCARE
Industry
BIOTECHNOLOGY
Market Cap
$501.01M
P/E Ratio
None
EPS
$-0.24
Beta
2.308
Dividend Yield
0.00%
52-Week High
$2.725
52-Week Low
$0.64

Similar stocks in BIOTECHNOLOGY

BNTX
BioNTech SE
RSI 44.0
VRTX
Vertex Pharmaceuticals Inc
RSI 50.0
CRSP
CRISPR Therapeutics AG
RSI 55.0
RXRX
Recursion Pharmaceuticals Inc - Class A
RSI 66.0
MRNA
Moderna Inc
RSI 41.0
VKTX
Viking Therapeutics Inc
RSI 48.0
SRPT
Sarepta Therapeutics Inc
RSI 42.0
EDIT
Editas Medicine Inc
RSI 59.0
IOVA
Iovance Biotherapeutics Inc
RSI 54.0
NVAX
Novavax Inc
RSI 60.0

Data last updated: May 13, 2026 at 5:09 AM EDT

Track OCGN for free

Get e-mail RSI alerts when Ocugen Inc enters oversold or overbought territory. Free forever.

Add Alert